Clinical Trial Update: Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating toripalimab in combination with chemotherapy as adjuvant therapy for stage IB-IIIB non-small cell lung cancer, with or witho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Wen-zhao ZHONG | Conditions: Stage IB-IIIB NSCLC, Stage IIB-III NSCLC | Phase 2 | Status: RECRUITING